Exchange: OTC·Updated 02:47 PM EDT

MDNAFMedicenna Therapeutics Corp

$0.2906
$0.0063
(2.22%)
Today
Reported EarningsFeb 13
Mkt Cap$19.98M
Vol92,467.00
News
all
press releases
News Placeholder
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
<
...
1
>
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.